1 |
Vermeij FH, Scholte op Reimer WJ, De Man P, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey[J]. Cerebrovasc Dis, 2009, 27(5): 465-471.
|
2 |
Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine[J]. Stroke, 2003, 34(4): 975-981.
|
3 |
Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients[J]. Stroke, 2011, 42(11): 3214-3218.
|
4 |
Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke[J]. Neurology, 2011, 77(14): 1338-1345.
|
5 |
Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group[J]. Stroke, 2015, 46(8): 2335-2340.
|
6 |
Metheny NA. Risk factors for aspiration[J]. JPEN J Parenter Enteral Nutr, 2002, 26(6 suppl): s26-s31.
|
7 |
Ovbiagele B, Hills NK, Saver JL, et al. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization[J]. J Stroke Cerebrovasc Dis, 2006, 15(5): 209-213.
|
8 |
Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts[J]. Lancet Neurol, 2008, 7(4): 341-353.
|
9 |
Haeusler KG, Schmidt WU, Föhring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans[J]. Cerebrovasc Dis, 2007, 25(1-2): 50-58.
|
10 |
郑磊,郭红梅. 晚发的卒中相关性肺炎39例临床分析[J]. 安徽医药,2013, 17(1): 85-87.
|
11 |
刘晓玲,李静燕,张鹏,等. 围手术期质子泵抑制剂预防应激性溃疡用药分析[J]. 实用药物与临床,2015, 18(4): 496-499.
|
12 |
Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia[J]. Jama, 2009, 301(20): 2120-2128.
|
13 |
Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study[J]. Gut, 1996, 39(1): 54-59.
|
14 |
Aybay C, Imir T, Okur H. The effect of omeprazole on human natural killer cell activity[J]. Gen Pharmac, 1995, 26(6): 1416-1418.
|
15 |
陈钊成,吴海桂,林伟明,等. 卒中相关性肺炎病原茵及耐药性分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(3): 348-350.
|
16 |
Alkim H, Unal S, Okur H, et al. Omeprazole inhibits natural killer cell functions [J]. Dig Dis Sci, 2008, 53(2): 347-351.
|
17 |
Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs[J]. Jama, 2004, 292(16): 1955-1960.
|
18 |
Chen CH, Lin HC, Lin HL, et al. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease[J]. J Microbiol Immunol Infect, 2015, 48(4): 390-396.
|
19 |
Ho SW, Tsai MC, Teng YH, et al. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors[J]. BMJ open, 2014, 4(11): e006710.
|
20 |
Ho SW, Hsieh MJ, Yang SF, et al. Risk of stroke-associated pneumonia with acid-suppressive drugs: A population-based cohort study[J]. Medicine, 2015, 94(29): e1227.
|
21 |
柏愚,李延青,任旭,等. 应激性溃疡防治专家建议(2015版)[J]. 中华医学杂志,2015, 95(20): 1155-1157.
|
22 |
赵玉沛. 应激性黏膜病变预防与治疗-中国普通外科专家共识(2015)[J]. 中国实用外科杂志,2015, 35(7): 728-730.
|
23 |
Cuillamondegui OD, Cunter OI, Bonadies J, et al. Practice management guidelines for stress ulcer prophylaxis[J]. Chicago, IL:Eastern Association for the Surgery of Trauma, 2008: 1-24.
|